505 Results

People

  1. Herr
    Herr
  2. Bochner
    Bochner
  3. Dalbagni
    Dalbagni
  4. Donat
    Donat
  5. Cordon-Cardo
    Cordon-Cardo
  6. Reuter
    Reuter
  7. Al-Ahmadie
    Al-Ahmadie
  8. Bajorin
    Bajorin
  9. Rosenberg
    Rosenberg
  10. Fair
    Fair

Groups

  1. Surgery (296)
  2. Urology (286)
  3. Department of Medicine (97)
  4. Solid Tumor Oncology Division (94)
  5. Department of Pathology and Laboratory Medicine (89)
  6. Genitourinary Oncology Service (88)
  7. Epidemiology and Biostatistics (51)
  8. Population Sciences Research Program (37)
  9. Survivorship Research (36)
  10. GSK Faculty (30)
  1. "urinary bladder neoplasms"
Formats
  1. Journal Article (468)
  2. Review (23)
  3. Editorial (5)
  4. Conference Paper (3)
  5. Guidelines (3)
  6. Book Section (2)
  7. Correspondence (1)
Groups
  1. Surgery (296)
  2. Urology (286)
  3. Department of Medicine (97)
  4. Solid Tumor Oncology Division (94)
  5. Department of Pathology and Laboratory Medicine (89)
  6. Genitourinary Oncology Service (88)

More Groups

People
  1. Harry Herr (172)
  2. Bernard Bochner (92)
  3. Guido Dalbagni (89)
  4. Sherri Donat (66)
  5. Carlos Cordon-Cardo (62)
  6. Victor Reuter (51)

More People

Years
  1. 2025 (6)
  2. 2024 (21)
  3. 2023 (34)
  4. 2022 (25)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Urology (99)
  2. European Urology (35)
  3. BJU International (29)
  4. Cancer (23)
  5. Urology (23)
  6. Clinical Cancer Research (20)

More Publications

Publishers
  1. Elsevier Science, Inc. (166)
  2. Wiley Blackwell (61)
  3. Elsevier Inc. (41)
  4. American Association for Cancer Research (39)
  5. Nature Publishing Group (22)
  6. Springer (20)

More Publishers

Results (505)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating nonmuscle invasive bladder cancer
    Journal Article

    Bellat, V.; Michel, A. O.; Thomas, C.; Stokol, T.; Choi, B. B.; Law, B.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Health-related quality of life of patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin after platinum and PD-1/PD-L1 inhibitor therapy: Results from cohort 1 of the phase 2 EV-201 clinical trial
    Journal Article

    McGregor, B.; O'Donnell, P. H.; Balar, A.; Petrylak, D.; Rosenberg, J.; Yu, E. Y.; Quinn, D. I.; Heath, E. I.; Campbell, M.; Hepp, Z.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy
    Journal Article

    Almassi, N.; Vertosick, E. A.; Sjoberg, D. D.; Wong, N. C.; Huang, C.; Pietzak, E. J.; Cha, E. K.; Donahue, T. F.; Dalbagni, G.; Bochner, B. H.; more...
    BJU International (2022)

    Fulltext@MSK | Save
  • Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report
    Journal Article

    Matin, S. F.; Pierorazio, P. M.; Kleinmann, N.; Gore, J. L.; Shabsigh, A.; Hu, B.; Chamie, K.; Godoy, G.; Hubosky, S. G.; Rivera, M.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Cisplatin, neoadjuvant chemotherapy and bladder cancer
    Editorial

    Herr, H.; Soloway, M.
    Urology (2022)

    Fulltext@MSK | Save
  • Assessment of tobacco screening and smoking cessation recommendations among bladder cancer guidelines: A call to action
    Editorial

    Michael, J.; Matulewicz, R. S.; Bjurlin, M. A.
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Bladder cancer genomics: Indications for sequencing and diagnostic implications
    Book Section

    Lenis, A. T.; Pietzak, E. J.
    In Bjurlin, M. A.; Matulewicz, R. S. (Eds.) Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers (2021)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
    Guidelines

    Galsky, M. D.; Balar, A. V.; Black, P. C.; Campbell, M. T.; Dykstra, G. S.; Grivas, P.; Gupta, S.; Hoimes, C. J.; Lopez, L. P.; Meeks, J. J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Examining the accuracy of self-reported smoking-related exposure among recently diagnosed nonmuscle invasive bladder cancer patients
    Journal Article

    Petruzella, S.; Bochner, B. H.; Kenney, J.; Whiting, K.; Sadeghi, K.; Benfante, N.; Cha, E. K.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Sequencing of PD-1/L1 inhibitors and carboplatin based chemotherapy for cisplatin ineligible metastatic urothelial carcinoma
    Journal Article

    Wei, X. X.; Werner, L.; Teo, M. Y.; Rosenberg, J. E.; Koshkin, V. S.; Grivas, P.; Szabados, B.; Morrison, L.; Powles, T.; Carril-Ajuria, L.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save